Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)

Historical Holders from Q4 2019 to Q4 2024

Symbol
APRE on Nasdaq
Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
5.43M
All holders as of 31 Dec 2024
Q4 2024
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-1
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HIRSCHMAN ORIN 9.9% $270K 539K Orin Hirschman 31 Dec 2024
Sio Capital Management, LLC 5.09% $138K 277K Sio Capital Management, LLC 31 Dec 2024

Institutional Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 0 $0 -$2K 0
2024 Q3 899 $2K $2.22 1
2024 Q2 899 $3K -$669 $3.34 1
2024 Q1 999 $6.67K +$6K $6.68 2
2023 Q4 100 $470 $4.70 1
2023 Q3 100 $417 $4.17 1
2023 Q2 100 $315 -$13 $3.15 1
2023 Q1 103 $457 -$520K $4.39 2
2022 Q4 1.59M $520K -$37.7K $0.33 23
2022 Q3 1.7M $1.11M -$365K $0.65 23
2022 Q2 2.03M $1.52M -$806K $0.75 29
2022 Q1 2.42M $4.5M -$2.77M $1.86 38
2021 Q4 3.61M $10.4M -$8.43M $2.87 35
2021 Q3 5M $25.5M -$7.57M $5.11 37
2021 Q2 6.54M $31.9M -$12M $4.88 48
2021 Q1 8.93M $45.4M -$6.61M $5.10 64
2020 Q4 10.3M $50.8M -$96.4M $4.92 63
2020 Q3 16.8M $405M +$5.64M $24.06 65
2020 Q2 16.5M $639M +$117M $38.78 64
2020 Q1 13.5M $467M +$18.8M $34.76 50
2019 Q4 12.9M $591M +$460M $45.89 39